Overview of Dental Plaque Development

As previously stated, more than 500 different bacterial species can be found in the oral cavity (95). The sites colonized by these different microorganisms are diverse, ranging from the nonshedding tooth surface to the continually shedding epithelium covering the mucosal surfaces. The microorganisms colonizing these surfaces are not present in a free-floating planktonic state. Rather, they are present as a biofilm—a "community of microorganisms attached to a surface" (98). While the communities found on soft tissues often comprise a single microbial species, the most prevalent oral biofilm, dental plaque, exists as a complex multispecies entity attached to the tooth surface.

Within this multispecies biofilm are grampositive, gram-negative, aerobic, facultative, and anaerobic microorganisms that are deposited on the tooth surface in a sequential fashion. This sequential deposition begins with the adherence of early colonizers, streptococci and actinomycetes spp., to host-derived glycoproteins, mucins, and other proteins coating the tooth surface (41). These salivary proteins are deposited within minutes on a clean tooth surface and are called the "acquired pellicle." Bacterial surface structures, such as pili and outer membrane proteins, as well as proteins and enzymes in the acquired pellicle, are important mediators of this initial attachment (19, 37, 42).

Continued development of the plaque biofilm relies on physical interaction of bacteria of the same or different genera through coaggregation and coadhesion (68). Lectin-like receptors appear to be involved in coaggregation among streptococci, and lipoproteins and pili play a role in cell-cell interactions among other early colonizers. The biofilm continues to develop as late colonizers, such as veillonellae, prevotellae, propionibacteria, and certain streptococci, begin to colonize the tooth surface (98). Many of these bacteria would not usually interact with each other in a way that results in aggregation. However, certain bacteria, such as Fusobacterium nucleatum, serve as important bridges between these noncoaggregating, early colonizing bacteria and the late colonizers (68).

As the biofilm begins to mature, there is a progressive shift from a gram-positive, facultative flora to one predominated by gram-negative, anaerobic species. This shift is associated with the development of the biofilm beneath the gingival surface. The supragingival (above the gingival surface) and subgingival (beneath the gingival surface) habitats differ in terms of pH, redox potential, and nutrient availability. In addition, salivary and masticatory influences that have an impact on the supragingival microflora do not have the same influence on subgingival bacteria (7). Subgingival plaque is either designated as tooth-associated or tissue-associated. The tooth-associated plaque primarily comprises gram-positive rods and cocci, whereas the plaque associated with the epithelial tissue lining the gingival crevice is predominated by gramnegative rods, filaments, and spirochetes. Increased prevalence of several genera of proposed importance in the development of periodontitis may be seen as the subgingival plaque matures. These genera include, but are not limited to, Treponema, Bacteroides, Porphyromonas, Prevotella, Capnocytophaga, Peptostreptococcus, Fusobacterium, Actinobacillus, and Eikenella.

Certain periodontal bacteria are often found together in subgingival plaque samples. Cluster analysis and community ordination techniques were used to further define these relationships and to determine whether there were correlations between certain clusters and clinical parameters of disease (128). Results of these studies demonstrated that the bacteria could be sorted into five major groups that were given color designations. The designated "red" complex (Treponema denticola, Porphyromonas gingivalis, and Bacteroides forsythus) and the "orange" complex (Prevotella intermedia, Prevotella nigrescens, Peptostreptococcus micros, F. nucleatum subspecies, Eubacterium nodatum, Streptococcus constellatus, and three Campylobacter species) were generally found together, and evidence showed that colonization by the red complex was preceded by colonization by orange complex species. Both complexes could be associated with clinical parameters of disease supporting the polymicrobial nature of periodontitis.

Although it is clear that periodontal disease is a polymicrobial infection, there has historically been an interest in identifying specific microorganisms that contribute to the disease process. Attempts to apply Koch's postulates to specific bacteria have been hampered because these pathogens often cannot be grown in pure culture (e.g., large spirochetes), they may have long incubation times, they can occur in an asymptomatic carrier state, and they may exhibit a limited host range (121). Socransky (126) proposed a modified series of criteria for microbial causation for periodontitis which included (i) association of the microorganism with periodontitis, (ii) demonstration that elimination of the bacteria reduced the disease, (iii) evidence of a host response to the pathogen, (iv) demonstration of ability of the pathogen to cause disease in an animal model, and (v) evidence that the pathogen produces virulence factors that contribute to the disease process (126). Following this approach, three bacteria have been recognized as causative agents of periodontitis: P. gingivalis, A. actinomycetemcomitans, and B. forsythus (40). Although not completely supported by these criteria for causation, there is also evidence that E. nodatum, Campylobacter rectus, P. intermedia/nigrescens, P. micros, and T. denticola are etiologic factors in periodontitis (40).

Pathogenic Potential of Periodontal Pathogens

Pathogenic bacteria must be able to (i) colonize the host, (ii) evade host defense mechanisms, and (iii) damage host tissues. Mechanisms for each of these required steps for pathogenesis have been identified for many of the periodontal pathogens. The purpose of this section is not to provide an exhaustive evaluation of each of these mechanisms. Rather, examples of pathogenic processes used by selected periodontal pathogens are presented with appropriate review articles listed for further reference.

Adherence, Colonization, and Growth

As discussed in the section on development of the biofilm, adhesion is a necessary element in the colonization of subgingival bacteria, either directly to the periodontal tissues or through the association with other organisms by coaggregation and coadhesion. As the biofilm develops, there are areas of high and low bacterial biomass interlaced with aqueous channels which will provide for movement of essential nutrients (derived primarily from the gingival crevicular fluid) for the growth of the organisms and removal of metabolic waste products (24). While the space limitations of the subgingival environment (pocket) attempt to limit the expansion of the subgingival microbial complex, the apical migration of the epithelium and destruction of the attachment apparatus adjacent to the tooth (deeper periodontal pockets) allows for expansion of the subgingival biomass. As a result of the polymicrobial infection, the bacteria act in concert supporting nutrition and aggregation factors necessary for the biofilm development. For example, bacterial derived proteinases destroy tissue providing polypeptides utilized for growth by other organisms (62).

Although primarily a subgingival microorganism, P. gingivalis can adhere to many of the early plaque formers (80). For example, adherence between P. gingivalis and Actinomyces naeslundii is mediated by fimbrillin and a 40-kDa membrane protein of P. gingivalis and a high molecular weight carbohydrate on A. naeslundii. P. gingivalis can also interact with later colonizers such as F. nucleatum, T. denticola, Treponema medium, and B. forsythus. These interactions promote P. gingivalis colonization of the plaque biofilm. On the host side, P. gingivalis also can bind to epithelial cells, fibroblasts, and erythrocytes, and to components of the extracellular matrix. These interactions are mediated by P. gingivalis fimbriae and may be facilitated by proteolytic enzymes (80).

T. denticola attaches to human gingival fibroblasts, possibly through a lectin-mediated mechanism. Most strains adhere well to extracellular and basement membrane proteins, such as fibronectin and laminin (17). T. denticola coaggregates with F. nucleatum and P. gingivalis, which may be an important factor in colonization and development of the plaque biofilm (61).

Other important periodontal pathogens are also known for their ability to aggregate and/or adhere. For example, A. actinomycetemcomitans adheres to the tooth or epithelium via surface proteins, microvesicles, and fimbrae (139). P. micros adherence to epithelial cells has been shown to vary with morphologic characteristics of particular strains (74). And Eikenella corrodens demonstrates an aggregating factor, which is believed to play an important role in the accumulation of plaque (32).

Interference with Host Defenses

Periodontal pathogens use a variety of means to interfere with host defense mechanisms, thereby prolonging their presence in the periodontal pocket. One of the best-studied virulence factors is the leukotoxin produced by A. actinomycetemcomitans. This cytotoxic protein specifically kills a subset of leukocytes in vitro that includes polymorphonuclear leukocytes and peripheral blood monocytes (10, 134). The leukotoxin gene was cloned and sequenced (69, 73, 76, 77) and, on the basis of sequence homology, was found to be a member of the RTX (repeats in toxin) family of pore-forming bacterial toxins including toxins from such other species as Pasteurella haemolytica and Actinobacillus pleuropneumoniae, producing devastating infections in cattle and swine, respectively. The members of the RTX family all share a common gene organization, and the toxins contain tandemly repeated nonapeptides that have the consensus sequence GGXGXDX(L/I/V/W/Y/F)X.

A. actinomycetemcomitans elaborates many other factors that may allow the organism to evade detection/destruction by the host's immune system. These include inhibition of polymorphonuclear chemotaxis, production of immunosuppressive factors, secretion of proteases, which cleave immunoglobulin G (IgG), and production of Fc binding proteins (139). Recently, the organism was also shown to produce a cytolethal distending toxin (CDT) (88, 117, 130). The CDT of A. actinomycetemcomitans (previously described as the immunosuppressive factor) (115, 117, 118) induces cell cycle arrest in lymphocytes. The biological effects of the CDT, however, extend beyond immunosuppression and could play a role in other phenomena associated with A. actinomycetemcomitans including cell invasion (90, 91, 93).

P. gingivalis produces proteinases that cleave IgA1, IgA2, and IgG (36, 66, 67), including hydrolysis of immunoglobulin already bound to the bacterial surface (48). The lipopolysaccharide (LPS) produced by P. gingivalis does not stimulate E-selectin expression on endothelial cells and therefore hinders leukocyte extravasation (26). P. gingivalis LPS also is a poor activator of the release of tumor necrosis factor by mononuclear cells (22). P. gingivalis produces a capsule that inhibits phagocytosis and decreases interactions with bacterial serum proteins (131); this resistance to phagocytosis varies between strains (20). Other proteinases produced by P. gingivalis render polymorphonuclear leukocytes inactive (102).

Tissue Penetration and Invasion

One of the hallmarks of pathogenesis is the ability of the pathogenic microorganism to invade surrounding tissues, yet another mechanism to evade the host defense. Here, the bacteria may survive, replicate, and eventually be released back into the extracellular environment. Currently, evidence of host cell invasion exists for A. actinomycetemcomitans, P. gingivalis, P. intermedia, and F. nucleatum.

The invasive ability of A. actinomycetemcomitans has been demonstrated in vitro using a human epidermoid carcinoma cell line (KB) that is of oral origin (34, 35). The efficiency of invasion varies among the clinical and laboratory isolates examined. A. actinomycetemcomitans is taken up in a host-derived membrane-bound vacuole by an active process involving signaling between the bacterium and KB cell microvilli (129). Primary and secondary receptors for uptake may be the transferrin receptor and integrins, respectively (92, 107). Following uptake, A. actinomycetemcomitans subsequently escapes from the vacuole, replicates rapidly in the cytoplasm, and is transmitted to adjacent cells through bacteria-induced protrusions of the host cell membrane. Through these processes, A. actinomycetemcomitans may not only evade host defenses but also gain access to underlying periodontal tissues.

As seen with A. actinomycetemcomitans, invasion of primary cultures of gingival epithelial cells by P. gingivalis is an active process that requires energy production by both the epithelial cell and the bacterium (58, 79). While clinical and laboratory strains have the ability to invade epithelial cells, considerable variation occurs in the invasive potential among the various strains (109). Internalization of P. gingivalis involves a receptor-mediated endocytosis pathway (108). Protease inhibitors can inhibit invasion, suggesting a role for P. gingivalis proteases in the invasion process. Invasion of epithelial cells by P. gingivalis results in an interleukin-1β (IL-1β) mRNA response, decreased IL-8 accumulation (25), and inhibition of neutrophil migration through the epithelium (84), all factors that have an impact on the host defense system. P. gingivalis also can replicate and persist within KB cells (85). Additional evidence has shown that P. gingivalis can invade human endothelial cells by a mechanism that involves fimbriae, cytoskeletal rearrangements, protein phosphorylation, energy metabolism, and P. gingivalis proteases (28).

Invasive capabilities have been evaluated for other periodontal pathogens. For example, a single clinical isolate of P. intermedia was shown to invade a KB cell line. The type C fimbriae and a cytoskeletal rearrangement were required for this invasion. However, neither a different clinical isolate nor the type strain was able to invade the cell line (29). F. nucleatum also adheres to and invades primary cultures of human gingival epithelial cells (55). Invasion is via a "zipping" mechanism and requires the involvement of actins, microtubules, signal transduction, protein synthesis, and energy metabolism of the epithelial cell and protein synthesis by F. nucleatum. F. nucleatum invasion of epithelial cells is accompanied by high levels of IL-8 secretion. In this same study, B. forsythus, Campylobacter curvus, and E. corrodens were shown to be noninvasive.

In addition to invasion of the surrounding soft tissues, a recent study demonstrated the invasion of P. intermedia, P. gingivalis, F. nucleatum, B. forythus, P. micros, and S. intermedius in radicular dentin (43). Thus, the tooth itself may serve as a reservoir for bacterial colonization.

Damage to the Host

Although the primary cause for connective tissue destruction is the result of proteolytic activity of host cells, bacteria produce several enzymes that damage the extracellular matrix proteins, including collagenase.

P. gingivalis produces numerous hydrolytic, proteolytic, and lipolytic enzymes (58). Among the proteolytic enzymes are two cysteine proteases (gingipains). There are indications that these proteases are involved in several functions including adherence to host cells, inhibition of host defenses, and damage to host cells. They appear to contribute to the local generation of the proinflammatory molecules, bradykinin and thrombin, ultimately having an indirect effect on bone resorption (102).

Human gingival fibroblasts incubated with T. denticola demonstrate a variety of pathologic responses, including cell detachment, reduced cell proliferation, and cell death (33). This pathogen also can agglutinate and lyse red blood cells (47) and induce membrane blebbing of epithelial cells (17). In addition, it has been proposed that T. denticola outer sheath components, such as surface proteases, membrane lipids, and lipoproteins, may contribute to the induction of an inflammatory reaction in the periodontal tissues that can contribute to tissue damage (61).

A. actinomycetemcomitans LPS and acid and alkaline phosphatases induce bone resorption (60), and collagenolytic activity has been observed in both media and cell sonicates of the organism (105). A. actinomycetemcomitans also produces a factor that inhibits fibroblast proliferation in cell cultures and their production of substances of the extracellular matrix, thus modulating tissue turnover (116).

In addition to the independent virulence mechanisms by individual species and strains, complex, interdependent interactions also exist that occur among the different genera in the plaque biofilm, which can affect their pathogenic potential. For example, it has been suggested that F. nucleatum may have a synergistic interaction with P. gingivalis. F. nucleatum binds plasminogen that can be converted by protease activity to plasmin (23). The conversion of the cell-bound plasminogen to plasmin may allow F. nucleatum to evade host defenses and to invade tissues. P. gingivalis, a coaggregation partner with F. nucleatum, may provide the proteolytic activity needed for this conversion (68). A synergistic effect is also seen with A. actinomycetemcomitans and P. gingivalis where a coinfection with these organisms showed enhanced induction of the humoral and cell-mediated response (18). In contrast, the mixed microbial milieu may be beneficial in suppressing growth of various species, inhibiting expression of various virulence factors or neutralizing virulence factors. For instance, H₂O₂ production by Streptococcus sanguis is lethal to A. actinomycetemcomitans (127), and the leukotoxicity of A. actinomycetemcomitans was recently shown to be inhibited by other subgingival inhabitants (P. gingivalis, P. intermedia, P. nigrescens, Prevotella melaninogenica, and Prevotella loeschii) (63).

In summary, many proposed virulence factors have been identified for specific periodontal pathogens. Development of dental plaque and subsequent tissue destruction, however, rely on complex interactions among these bacteria in the biofilm environment. Although the nature of these interactions in biofilm development is currently being investigated in in vivo model systems, many of the previous studies were based on in vitro assays on either planktonic cells or in vitro-generated biofilms. It is becoming clear that, while these assays do provide important information on specific pathogenic properties, they may not accurately mimic the in vivo environment. Therefore, additional studies are necessary to better define the roles of proposed periodontal pathogens and their virulence factors in vivo in the destructive processes of periodontal disease.

Innate Host Response

Despite the importance of infection and colonization by bacteria in periodontal infections, the immune status of the host and effectiveness of the host response are key determinants of disease susceptibility.

In periodontal disease, bacterial colonization of the subgingival area results in both an innate host response and an acquired immune response. Even in the presence of such immune responses, the bacterial challenge may be too severe to overcome. The result is the initiation and progression of periodontitis. Alternatively, periodontal disease may be found in individuals with defects in either their innate or acquired immunity which limits their ability to mount an adequate response. Evidence is accumulating supporting the host response as a major determinant of disease susceptibility.

Innate immunity plays a significant role in the response to microbial colonization seen in periodontal diseases. As a part of the innate response, secretory IgA and numerous enzymes and antimicrobial factors present in the saliva neutralize microbial components. These factors include lysozyme, lactoferrin, peroxidases, antimicrobial peptides, histatins, defensins, and cathelicidins (78, 113). All these factors attempt to minimize the effect of the offending biofilm complex and may function synergistically.

As plaque extends subgingivally, the flora becomes more complex and exists in a more protected environment. The immune response also changes. Salivary components no longer have access to the bacteria colonizing the subgingival environment. However, the crevicular fluid bathing the gingival sulcus or pocket contains many factors capable of resisting bacterial progression such as lysozyme, bradykinin, thrombin, fibrinogen, complement, antibodies, and neutrophil-derived components (24).

Recent investigations have looked toward defensins (innate immune peptides with antimicrobial properties) and their role in periodontal and other oral infections. The α (classical)-defensins are found in the primary granules of neutrophils and are believed to produce their antimicrobial activity by forming channels in the bacterial or fungal membranes. These channels increase membrane permeability in a charge- or voltage-dependent manner, ultimately resulting in cell lysis or cell death (65).

The cationic β-defensins produced by epithelial cells represent a local defense mechanism in contrast to the more systemic response seen with the neutrophil-derived α-defensins. Three β-defensins, HBD-1, HBD-2, and HBD-3, are expressed in the gingival epithelial tissue, which makes them excellent candidate peptides contributing to the defenses at mucosal surfaces, including the periodontium (75, 87). In addition, β-defensin expression on other mucosal surfaces, such as buccal mucosa, tongue, and salivary derived defensins, may limit initial bacterial colonization by certain periodontal pathogens (75, 87, 114). In vitro, β-defensins exhibit broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria and fungi (38). Although the specific antimicrobial mechanism for the β-defensins is not known, they are believed to act similarly to the α-defensins.

The neutrophil response is the host's first innate cellular response and probably the most significant in limiting the subgingival biofilm accumulation (24). As reviewed by Dennison and Van Dyke (27), the pivotal role of these cells in protection from periodontal diseases has been proven, because individuals with a decreased number or function demonstrate a marked increase in susceptibility to rapid and severe periodontal destruction.

Adaptive Host Response

The importance and correlation of adaptive/acquired immunity in periodontal diseases is proven by several factors. First, there is an elevation in the cell-mediated (both CD4⁺ and CD8⁺ cellular response) or humoral response (a composite of antibodies) with the presence of periodontitis and increasing severity of periodontitis. Second, both systemic and local antibody formation have been demonstrated following mechanical periodontal therapy most likely as a result of a treatment-induced bacteremia. Third, antibody formation is specific for specific periodontal organisms, i.e., A. actinomycetemcomitans, P. gingivalis, P. intermedia, F. nucleatum, Capnocytophaga gingivalis, Capnocytophaga ochracea, Capnocytophaga sputigena, E. corrodens, C. rectus, oral spirochetes, and is specific for certain virulence factors such as the leukotoxin and other components of A. actinomycetemcomitans and the capsule of P. gingivalis (30). However, the protective role of the adaptive immune response is not fully understood. This may be because both antibody titers and function (avidity) may vary with the patient's age and disease, making some individuals more or less susceptible to tissue breakdown (30). In certain populations, the protective role of antibodies has been demonstrated. For example, higher titers of an antibody reactive to the LPS of a virulent strain of A. actinomycetemcomitans (serotype B) was shown to be protective for young individuals with generalized aggressive disease (15).

For most people suffering from periodontal disease, it is hypothesized that the innate and acquired immune responses are protective resulting either in minimal periodontal destruction or an arrested disease state. In individuals in whom either the innate or acquired response is altered, the result is likely to be aggressive/progressive destruction. An example of this is aggressive periodontitis where numerous studies have demonstrated abnormalities in neutrophil function. It is believed that it must be a "mild" alteration in function, because there may be no apparent infections elsewhere in the body (102).

The Host Response: A Double-edged Sword

Although bacteria are capable of directly causing destruction of the periodontal tissues, most of the destruction that occurs is a result of an indirect process whereby host cells are activated producing tissue-degradative substances. Consequently, the host's protective nature may by countered by its destructive potential. Cytokines such as IL-1, IL-6, and IL-8 are likely to be important in the destructive process (5). IL-1 promotes bone resorption, stimulates release of the eicosanoid prostaglandin E₂ (PGE₂) by monocytes and fibroblasts, and stimulates the release of matrix metalloproteinases (MMPs) important in degradation of the extracellular matrix. IL-6 stimulates osteoclast formation and therefore may also play a role in bone resorption. IL-8, a chemoattractant for neutrophils, selectively stimulates MMP activity from these cells. Each of these cytokines is found in elevated levels in inflamed gingival tissues. Other tissue-destructive host-derived factors include tumor necrosis factor alpha and PGE₂, both of which stimulate MMP production and induce bone resorption. The individual or combined actions of these inflammatory molecules can result in significant tissue destruction.

Nonbacterial Risk Factors in Periondontal Disease

Bacterial plaque is the primary etiologic factor associated with periodontitis, yet there are several other variables that may place an individual at risk for developing disease (3, 99, 100, 101). Two of these variables are clearly defined risk factors: tobacco smoking and diabetes. A direct relationship exists between periodontal disease and the prevalence of smoking, and the prevalence and severity of periodontitis is significantly higher in patients with type I and type II diabetes. Several other less clearly defined factors should be included as part of a risk assessment for each patient. These include genetic factors, age, gender, socioeconomic status, stress, human immunodeficiency virus infection/acquired immunodeficiency syndrome, osteoporosis, infrequent dental visits, previous history of periodontal disease, and bleeding on probing.

Until recently, aggressive periodontal diseases were unique in their risk associated with genetic predisposition. A unique genetic marker for chronic periodontitis recently linked this form of periodontal disease to an inherited allele responsible for IL-1β overproduction (71). More studies are currently underway to define the role of this gene in other forms of periodontal disease and understand the significance it may have in performing and prescribing periodontal treatment. Meanwhile, twin studies demonstrate that chronic periodontitis has a 50% heritable component (94). These studies clearly demonstrate the multifactorial nature of periodontal diseases and the need for further research to better identify individuals at risk and for prescription of earlier and more definitive treatment.

Periodontal Therapy

The treatment of periodontal disease has primarily relied on mechanical therapy: root debridement performed either with or without surgical access to reduce the overall plaque mass. While specific microbial species are believed to play a role in the disease process, periodontal therapy today remains targeted toward removal of the plaque mass as opposed to elimination of specific pathogens. Benefits of mechanical debridement include: removal of calculus and endotoxin, disruption of the plaque biofilm complex, induction of potentially protective antibody responses to certain pathogens (31), and increased numbers of beneficial bacteria, such as streptococci (9). In addition, in the process of mechanical root debridement, specific subgingival pathogenic species are inadvertently removed or reduced to levels which result in improved clinical health and/or stabilization in periodontal maintenance patients (81, 103, 123).

Scaling and root planing (debridement) have routinely been shown to be effective in treatment of chronic periodontitis without the concomitant use of systemic or local antimicrobials (96). When performed as a part of routine periodontal maintenance, periodontal pathogens are suppressed to a level where an equilibrium is established between the host and the pathogen, which does not result in progressive loss of attachment in most patients (86, 112). Of equal importance is the necessity for good plaque control performed by the patient. Studies have shown that in shallow to moderately deep pockets, good oral hygiene can change the subgingival flora to one more compatible with periodontal health (138).

With the continued evolution of the specific plaque hypothesis, there is increased interest in chemical antimicrobials, which have the ability to suppress and/or eradicate the pathogenic players. In addition, periodontal pathogens, such as A. actinomycetemcomitans and P. gingivalis, that invade epithelium may not be as susceptible to standard mechanical debridement and require supplemental antibiotics and/or surgery for eradication (109, 129). Both systemic antimicrobials and locally delivered antimicrobial agents administered directly into periodontal pockets have been used in treatment of periodontal diseases.

Systemic antibiotics have been effective and are specifically recommended in the treatment of aggressive forms of periodontal disease (72, 136). In addition, they are effective in conjunction with scaling and root planing in deep periodontal pockets that are nonresponsive (46, 82, 137). Advantages of using systemic antibiotics in treatment of periodontal diseases include treatment of multiple sites and potential microbial reservoirs (tongue, tonsils, and buccal mucosa); treatment of organisms at the base of the pocket and in the tissue because of systemic absorption and delivery into oral tissues, gingival crevicular fluid, and saliva (137); availability of a variety of drugs and specific combinations from which to choose; and lower cost than locally delivered antimicrobials. Disadvantages of systemic antimicrobials include bacterial resistance, side effects (including superinfections and gastrointestinal irritation), compliance, and the fact that periodontal destruction is often localized to a few teeth.

Local delivery alleviates many concerns associated with systemic antibiotics and offers the ability to reach bacteria at the base of a pocket and retain activity for periods sufficient to have bactericidal or bacteristatic effects on offending pathogens. Considering that the gingival crevicular fluid is capable of being replaced 40 times in 1 h (45), the drug should ideally be substantive (retained on root surfaces) or be delivered in a slow- or controlled-release formulation. Local delivery results in a substantially higher drug concentration in the pocket than the equivalent systemic agent.

Local delivery of any antimicrobial is not, however, a substitute for systemic antibiotics when indicated in specific periodontal diseases. Antibiotic selection when choosing local delivery is empirical; therefore, in cases where one needs to know the specific bacteria and antimicrobial susceptibility (i.e., aggressive or nonresponsive disease), microbiologic testing and antibiotic susceptibility are recommended.

Periodontitis is a mixed infection. Today, drugs are available that target groups of microorganisms. However, broad-spectrum antibiotics are still widely used and have the disadvantage of killing beneficial bacteria as well. Judicious use of all antibiotics must be adhered to in light of this and increasing concerns of bacterial resistance. Finally, antimicrobials should not be used as a replacement for good mechanical therapy, but rather should be used in conjunction with mechanical therapy to optimize the therapeutic effectiveness of each. Although antimicrobials reduce the subgingival flora, their effectiveness against plaque as a part of a biofilm is not known. Bacterial life in a biofilm environment can be very different from the planktonic state. The architecture of the biofilm and its matrix may inhibit penetration of antimicrobials, the biofilm may contain inactivating substances, and phenotypic changes in biofilm bacteria, such as slower growth, may increase their resistance to antimicrobial agents. All of these factors may have an impact on the effectiveness of antimicrobial therapy. Therefore, as stated above, mechanical debridement remains an important component of periodontal therapy with antimicrobial therapy serving as an adjunct to this therapy.

Recently, new treatment strategies have been aimed at modulation of the host immunoinflammatory response. Therapeutic strategies now being used in clinical practice include administration of low-dose doxycycline, which inhibits matrix metalloproteinases, i.e., collagenase (16, 44). Other agents, which block specific cytokines or inhibit PGE₂, have also shown therapeutic potential and continue to be evaluated (70).

Finally, because of the complex microbial picture in the pathogenesis of periodontal diseases, the development of a vaccine for treatment of periodontal disease will not occur readily. Unlike other infections whereby treatment correlates with elimination of the offending pathogen, the successful treatment of this polymicrobial infection occurs not by elimination of pathogens but by an alteration where a level of symbioses or homeostasis can occur between the offending bacteria and the defensive host.

Summary

Periodontal diseases result from a polymicrobial infection of the subgingival crevice. Several primary players in the disease process have been identified and their virulence factors wellcharacterized. However, a vast number of pathogens potentially exist that have not been identified or characterized. The importance of the biofilm in plaque colonization and bacterial interactions and the impact these interactions have on expression or inhibition of specific virulence factors is not fully understood. What is realized, however, is that given the right combination of bacteria, indigenous colonizers may become opportunistic pathogens.

Currently, our therapy remains primarily directed toward controlling the bacterial etiology at the site of infection. Future treatment considerations should include reservoirs for the infection (i.e., buccal mucosa and tongue) and acquisition of the pathogens from family members (52, 135, 141). (Vertical and/or horizontal transmission has been shown both for A. actinomycetemcomitans and P. gingivalis [1, 2, 8, 133].) In addition, future research and treatment efforts will certainly continue in modulation of the host response and genetic heritability of periodontal diseases.

In the 19th and early 20th centuries, periodontal disease was believed to be a focus of oral sepsis serving as a seed of infection for inflammatory systemic diseases (59). The focal infection theory resulted in unnecessary and unsupported tooth extractions. In recent years, the connection of periodontal diseases with systemic diseases has been revisited and studies suggest that periodontal diseases may be a risk factor in preterm low birth weight deliveries, cardiovascular disease, diabetes, respiratory diseases, and other diseases (4). To support this, periodontal bacteria have been cultured from other target organs and prosthetic joints (49, 140). While the data are not entirely clear that periodontal diseases play a strong role in the development of other diseases, the systemic communications of this polymicrobial infection need to be further explored.

References

1.

Alaluusua S., Saarela M., Jousimies-Somer H., Asikainen S. Ribotyping shows intrafamilial similarity in Actinobacillus actinomycetemcomitans isolates. Oral Microbiol. Immunol. 1993;8:225–229. [PubMed: 7504235]

2.

Alaluusua S., Asikainen S., Lai C. H. Intrafamilial transmission of Actinobacillus actinomycetemcomitans. J. Periodontol. 1991;62:207–210. [PubMed: 2027073]

3.

American Academy of Periodontology. Position paper. Epidemiology of periodontal diseases. J. Periodontol. 1996;67:935–945. [PubMed: 8884652]

4.

American Academy of Periodontology. Position paper. Periodontal disease as a potential risk factor for systemic diseases. J. Periodontol. 1998;69:841–850. [PubMed: 9706864]

5.

American Academy of Periodontology. Informational paper. The pathogenesis of periodontal diseases. J. Periodontol. 1999;70:457–470. [PubMed: 10328661]

6.

Armitage G. C. Development of classification system for periodontal diseases and conditions. Ann. Periodontol. 1999;4:1–6. [PubMed: 10863370]

7.

Asikainen S., Chen C. Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol. 2000. 1999;20:65–81. [PubMed: 10522223]

8.

Asikainen S., Chen C., Slots J. Likelihood of transmitting Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in families with periodontitis. Oral Microbiol. Immunol. 1996;11:387–394. [PubMed: 9467371]

9.

Axelsson P., Lindhe J. The significance of maintenance care in the treatment of periodontal disease. J. Clin. Periodontol. 1981;8:281–294. [PubMed: 6947992]

10.

Baehni P., Tsai C. C., McArthur W. P., Hammond B. F., Taichman N. S. Interaction of inflammatory cells and oral microorganisms. VII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganisms. Infect. Immun. 1979;24:233–243. [PMC free article: PMC414288] [PubMed: 222679]

11.

Baer P. N. The case for periodontosis as a clinical entity. J. Periodontol. 1971;42:516–520. [PubMed: 5284178]

12.

Beaty T. H., Boughman J. A., Yang P., Astemborski J. A., Suzuki J. B. Genetic analysis of juvenile periodontitis in families ascertained through an affected proband. Am. J. Hum. Genet. 1987;40:443–452. [PMC free article: PMC1684137] [PubMed: 3578282]

13.

Boughman J. A., Halloran S. L., Roulston D., Schwartz S., Suzuki J. B., Weitkamp L. R., Wenk R. E., Wooten R., Cohen M. M. An autosomal-dominant form of juvenile periodontitis: its localization to chromosome 4 and linkage to dentinogenesis imperfecta and Gc. J. Craniofac. Genet. Dev. Biol. 1986;6:341–350. [PubMed: 3793857]

14.

Bueno L. C., Mayer M. P., DiRienzo J. M. Relationship between conversion of localized juvenile periodontitissusceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure. J. Periodontol. 1998;69:998–1007. [PMC free article: PMC3523333] [PubMed: 9776028]

15.

Califano J. V., Gunsolley J. C., Nakashima K., Schenkein H. A., Wilson M. E., Tew J. G. Influence of anti-Actinobacillus actinomycetemcomitans Y4 (serotype b) lipopolysaccharide on severity of generalized earlyonset periodontitis. Infect. Immun. 1996;64:3908–3910. [PMC free article: PMC174312] [PubMed: 8751948]

16.

Caton J. G. 1999Evaluation of Periostat for patient management Compend. Cont. Educ. Dent 20451–456., 458–460, 462. [PubMed: 10650360]

17.

Chan E. C. S., McLaughlin R. Taxonomy and virulence of oral spirochetes. Oral Microbiol. Immunol. 2000;15:1–9. [PubMed: 11155157]

18.

Chen P. B., Davern L. B., Katz J., Eldridge J. H., Michalek S. M. Host responses induced by co-infection with Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine model. Oral Microbiol. Immunol. 1996;11:274–281. [PubMed: 9002881]

19.

Clark W. B., Beem J. E., Nesbitt W. E., Cisar J. O., Tseng C. C., Levine M. J. Pellicle receptors for Actinomyces viscosus type I fimbriae in vitro. Infect. Immun. 1989;57:3003–3008. [PMC free article: PMC260762] [PubMed: 2570751]

20.

Conrads G., Herrler A., Moonen I., Lampert F., Schnitzler N. Flow cytometry to monitor phagocytosis and oxidative burst of anaerobic periodontopathogenic bacteria by human polymorphonuclear leukocytes. J. Periodontal Res. 1999;34:136–144. [PubMed: 10384401]

21.

Contreras A., Slots J. Herpesviruses in human periodontal disease. J. Periodontal Res. 2000;35:3–16. [PubMed: 10791704]

22.

Cunningham M. D., Seachord C., Ratcliffe K., Bainbridge B., Aruffo A., Darveau R. P. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infect. Immun. 1996;64:3601–3608. [PMC free article: PMC174269] [PubMed: 8751905]

23.

Darenfed J., Grenier D., Mayrand D. Acquisition of plasmin activity by Fusobacterium nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. Infect. Immun. 1999;67:6439–6444. [PMC free article: PMC97053] [PubMed: 10569761]

24.

Darveau R. P., Tanner A., Page R. C. The microbial challenge in periodontitis. Periodontol. 2000. 1997;14:12–32. [PubMed: 9567964]

25.

Darveau R. P., Belton C. M., Reife R. A., Lamont R. J. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 1998;66:1660–1665. [PMC free article: PMC108102] [PubMed: 9529095]

26.

Darveau R. P., Cunningham M. D., Bailey T., Seachord C., Ratcliffe K., Bainbridge B., Dietsch M., Page R. C., Aruffo A. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 1995;63:1311–1317. [PMC free article: PMC173152] [PubMed: 7534275]

27.

Dennison D. K., Van Dyke T. E. The acute inflammatory response and the role of phagocytic cells in periodontal health an disease. Periodontol. 2000. 1997;14:54–78. [PubMed: 9567966]

28.

Deshpande R. M., Kahn M. B., Genco C. A. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun. 1998;66:5337–5343. [PMC free article: PMC108667] [PubMed: 9784541]

29.

Dorn B. R., Leung K. L., Progulske-Fox A. Invasion of human oral epithelial cells by Prevotella intermedia. Infect. Immun. 1998;66:6054–6057. [PMC free article: PMC108773] [PubMed: 9826397]

30.

Ebersole J. L., Taubman M. A. The protective nature of host responses in periodontal diseases. Periodontol. 2000. 1994;5:112–141. [PubMed: 9673165]

31.

Ebersole J. L., Taubman M. A., Smith D. J., Haffajee A. D. Effect of subgingival scaling on systemic antibody responses to oral microorganisms. Infect. Immun. 1985;48:534–539. [PMC free article: PMC261367] [PubMed: 3886548]

32.

Ebisu S., Nakae H., Fukuhara H., Okada H. The mechanisms of Eikenella corrodens aggregation by salivary glycoprotein and the effect of the glycoprotein on oral bacterial aggregation. J. Periodontal Res. 1992;27:615–622. [PubMed: 1460548]

33.

Ellen R., Song M., McCullock C. Degradation of endogenous plasma membrane fibronectin concomitant with Treponema denticola 35405 adhesion to gingival fibroblasts. Infect. Immun. 1994;62:3033–3037. [PMC free article: PMC302918] [PubMed: 8005694]

34.

Fives-Taylor P. M., Neyer D. H., Mintz K. P., Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol. 2000. 1999;20:136–167. [PubMed: 10522226]

35.

Fives-Taylor P., Meyer D., Mintz K. Characteristics of Actinobacillus actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv. Dent. Res. 1993;9:55–62. [PubMed: 7669215]

36.

Frandsen E. V. G., Reinholdt J., Kilian M. Enzymatic and antigenic characterization of immunoglobulin A1 proteases from Bacteroides and Capnocytophaga spp. Infect. Immun. 1987;55:631–638. [PMC free article: PMC260386] [PubMed: 3546133]

37.

Ganeshkumar N., Song M., McBride B. C. Cloning of a Streptococcus sanguis adhesin which mediates binding to saliva-coated hydroxyapatite. Infect. Immun. 1988;56:1150–1157. [PMC free article: PMC259776] [PubMed: 3356463]

38.

Ganz T., Lehrer R. I. Defensins. Pharmacol. Ther. 1995;66:191–205. [PubMed: 7667395]

39.

Genco R. J. Current view of risk factors for periodontal diseases. J. Periodontol. 1996;67(Suppl.):1041–1049. [PubMed: 8910821]

40.

Genco R., Kornman D., Williams R., Offenbacher S., Zambon J., Ishikawa I., Listgarten M., Michalowicz B., Page R., Schenkein H., Slots J., Socransky S., Van Dyke T. Consensus report: periodontal diseases; pathogenesis and microbial factors. Ann. Periodontol. 1996;1:926–932.

41.

Gibbons, R. J., and J. van Houte. 1980. Bacterial adherence and the formation of dental plaques, p. 63–104. In E. H. Beachey (ed.), Bacterial Adherence. Chapman & Hall, London, United Kingdom.

42.

Gibbons R. J., Hay D. I., Schlesinger D. H. Delineation of a segment of adsorbed salivary acidic proline-rich proteins which promotes adhesion of Streptococcus gordonii to apatitic surfaces. Infect. Immun. 1991;59:2948– 2954. [PMC free article: PMC258118] [PubMed: 1879920]

43.

Giuliana G., Ammatuna P., Pizzo G., Capone F., D'Angelo M. Occurrence of invading bacteria in radicular dentin of periodontally diseased teeth: microbiological findings. J. Clin. Periodontol. 1997;24:478–485. [PubMed: 9226388]

44.

Golub L. M., Lee H. M., Ryan M. E., Giannobile W. V., Payne J., Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 1998;12:12–26. [PubMed: 9972117]

45.

Goodson J. M. Pharmacokinetic principles controlling efficacy of oral therapy. J. Dent. Res. 1989;68:1625–1632.

46.

Gordon J. M., Walker C. B., Lamster I., West T., Socransky S., Seiger M., Fasciano R. Efficacy of clindamycin hydrochloride in refractory periodontitis. 12 month results. J. Periodontol. 1985;56(Suppl):75–80. [PubMed: 3908641]

47.

Grenier D. Characteristics of hemolytic and hemagglutinating activities of Treponema denticola. Oral Microbiol. Immunol. 1991;6:246–249. [PubMed: 1812467]

48.

Grenier D., Mayrand D., McBride B. Further studies on the degradation of immunoglobulins by black-pigmented Bacteriodes. Oral Microbiol. Immunol. 1989;4:12–18. [PubMed: 2628862]

49.

Gristina A. G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237:1588–1595. [PubMed: 3629258]

50.

Grossi S. G., Zambon J. J., Ho A. W., Koch G., Dunford R. G., Machtei E. E., Norderyd O. M., Genco R. J. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J. Periodontol. 1994;65:260–267. [PubMed: 8164120]

51.

Grossi S. G., Genco R. J., Machtei E. E., Ho A. W., Koch G., Dunford R., Zambon J. J., Hausmann E. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J. Periodontol. 1995;66:23–29. [PubMed: 7891246]

52.

Gunsolley J. C., Ranney R. R., Zambon J. J., Burmeister J. A., Scheinkein H. A. Actinobacillus actinomycetemcomitans in families afflicted with periodontitis. J. Periodontol. 1990;61:643–648. [PubMed: 2231231]

53.

Guthmiller J. M., Lally E. T., Korostoff J. Beyond the specific plaque hypothesis: are highly leukotoxic strains of Actinobacillus actinomycetemcomitans a paradigm for periodontal pathogenesis? Crit. Rev. Oral Biol. Med. 2001;12:116–124. [PubMed: 11345522]

54.

Haffajee A. D., Socransky S. S. Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000. 1994;5:78–111. [PubMed: 9673164]

55.

Han T. W., Shi W., Huang G. T.-J., Kinder Haake S., Park N.-H., Kuramitsu H., Genco R. J. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect. Immun. 2000;68:3140–3146. [PMC free article: PMC97547] [PubMed: 10816455]

56.

Hart T. C., Marazita M. L., Schenkein H. A., Diehl S. R. Re-interpretation of the evidence for X-linked dominant inheritance of juvenile periodontitis. J. Periodontol. 1992;63:169–173. [PubMed: 1593411]

57.

Haubek D., Poulsen K., Westergaard J., Dahlen G., Kilian M. Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J. Clin. Microbiol. 1996;34:1576–1578. [PMC free article: PMC229068] [PubMed: 8735124]

58.

Holt S. C., Kesavalu L., Walker S., Genco C. A. Virulence factors of Porphyromonas gingivalis. Periodontol. 2000. 1999;20:168–238. [PubMed: 10522227]

59.

Hughes R. A. Focal infection revisited. Br. J. Rheumatol. 1994;33:370–377. [PubMed: 8156311]

60.

Iino Y., Hopps R. The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, and Capnocytophaga ochracea, isolated from human mouths. Arch. Oral Biol. 1984;29:59–63. [PubMed: 6362631]

61.

Ishihara K., Okuda K. Molecular pathogenesis of the cell surface proteins and lipids from Treponema denticola. FEMS Microbiol. Lett. 1999;181:199–204. [PubMed: 10585538]

62.

Jansen H. J., van der Hoeven J. S. Protein degradation by Prevotella intermedia and Actinomyces meyeri supports the growth of non-protein-cleaving oral bacteria in serum. J. Clin. Periodontol. 1997;24:346–353. [PubMed: 9178115]

63.

Johansson A., Hanstrom L., Kalfas S. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora. Oral Microbiol. Immunol. 2000;15:218– 225. [PubMed: 11154406]

64.

Jorgenson R. J., Levin L. S., Hutcherson S. T., Salinas C. F. Periodontosis in sibs. Oral Surg. 1975;39:396–402. [PubMed: 1054138]

65.

Kagan B. L., Selsted M. E., Ganz T., Lehrer R. I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA. 1990;87:210–214. [PMC free article: PMC53231] [PubMed: 1688654]

66.

Kilian M. Degradation of immunoglobulin A1, A2 and G by suspected principal periodontopathogens. Infect. Immun. 1981;34:757–765. [PMC free article: PMC350936] [PubMed: 7037640]

67.

Kilian M., Thomsen B., Petersen T. E., Bleeg H. Occurrence and nature of bacterial IgA proteases. Ann. N. Y. Acad. Sci. 1983;409:612–624. [PubMed: 6347000]

68.

Kolenbrander P. E. Oral microbial communities: biofilms, interactions and genetic systems. Annu. Rev. Microbiol. 2000;54:413–437. [PubMed: 11018133]

69.

Kolodrubetz D., Dailey T., Ebersole J., Kraig E. Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans. Infect. Immun. 1989;57:1465–1469. [PMC free article: PMC313300] [PubMed: 2707855]

70.

Kornman K. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin. Infect. Dis. 1999;28:520–526. [PubMed: 10194070]

71.

Kornman K. S., Crane A., Wang H. Y., di Giovine F. S., Newman M. G., Pirk F. W., Wilson, Jr T. G., Higginbottom F. L., Duff G. W. The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol. 1997;24:72–77. [PubMed: 9049801]

72.

Kornman K. S., Newman M. G., Moore D. J., Singer R. E. The influence of supragingival plaque control on clinical and microbial outcomes following the use of antibiotics for the treatment of periodontitis. J. Periodontol. 1994;65:848–854. [PubMed: 7990021]

73.

Kraig E., Dailey T., Kolodrubetz D. Nucleotide sequence of the leukotoxin gene from Actinobacillus actinomycetemcomitans: homology to the alpha-hemolysin/leukotoxin gene family. Infect. Immun. 1990;58:920–929. [PMC free article: PMC258561] [PubMed: 2318535]

74.

Kremer B. H. A., Herscheid A. J., Papaioannou W., Quirynen M., van Steenbergen T. J. M. Adherence of Peptostreptococcus micros morphotypes to epithelial cells in vitro. Oral Microbiol. Immunol. 1999;14:49–55. [PubMed: 10204480]

75.

Krisanaprakornkit S., Weinberg A., Perez C. N., Dale B. A. Expression of the peptide antibiotic human β-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect. Immun. 1998;66:4222–4228. [PMC free article: PMC108509] [PubMed: 9712771]

76.

Lally E. T., Golub E. E., Kieba I. R., Taichman N. S., Rosenbloom J., Rosenbloom J. C., Gibson C. W., Demuth D. R. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J. Biol. Chem. 1989;264:15451–15456. [PubMed: 2670940]

77.

Lally E. T., Kieba I. R., Demuth D. R., Rosenbloom J., Golub E. E., Taichman N. S., Gibson C. W. Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene. Biochem. Biophys. Res. Commun. 1989;159:256–262. [PubMed: 2647082]

78.

Lamkin M. S., Oppenheim F. G. Structural features of salivary function. Crit. Rev. Oral Biol. Med. 1993;4:251–259. [PubMed: 8373982]

79.

Lamont R. J., Chan A., Belton C. M., Izutsu K. T., Vasel D., Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect. Immun. 1995;63:3878–3885. [PMC free article: PMC173546] [PubMed: 7558295]

80.

Lamont R. J., Jenkinson H. F. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol. Immunol. 2000;15:341–349. [PubMed: 11154429]

81.

Listgarten M. A., Sullivan P., George C., Nitkin L., Rosenberg E. S., Chilton N. W., Kramer A. A. Comparative longitudinal study of 2 methods of scheduling maintenance visits: 4-year data. J. Clin. Periodontol. 1989;16:105–115. [PubMed: 2921370]

82.

Loesche W. J., Giordano J., Soehren S., Hutchinson R., Rau C. F., Walsh L., Schork M. A. Nonsurgical treatment of patients with periodontal disease. Oral Surg. Oral Med. Oral Pathol. 1996;81:533–543. [PubMed: 8734698]

83.

Loesche W. J. Chemotherapy of dental plaque infections. Oral Sci. Rev. 1976;9:65. [PubMed: 1067529]

84.

Madianos P. N., Papapanou P. N., Sandros J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect. Immun. 1997;65:3983–3990. [PMC free article: PMC175572] [PubMed: 9316996]

85.

Madianos P. N., Papapanou P. N., Nannmark U., Dahlén G., Sandros J. Porphyromonas gingivalis FDC381 multiplies and persists within human oral epithelial cells in vitro. Infect. Immun. 1996;64:660–664. [PMC free article: PMC173817] [PubMed: 8550223]

86.

Magnusson I., Lindhe J., Yoneyama T., Liljenberg B. Recolonization of a subgingival microbiota following scaling in deep pockets. J. Clin. Periodontol. 1984;11:193–207. [PubMed: 6368611]

87.

Mathews M., Jia H. P., Guthmiller J. M., Losh G., Graham S., Johnson G. K., Tack B. F., McCray, Jr P. B. Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 1999;67:2740–2745. [PMC free article: PMC96577] [PubMed: 10338476]

88.

Mayer M. P. A., Bueno L. C., Hansen E. J., DiRienzo J. M. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect. Immun. 1999;67:1227–1237. [PMC free article: PMC96451] [PubMed: 10024565]

89.

Melnick M., Shields E. D., Bixler D. Periodontosis: a phenotypic and genetic analysis. Oral Surg. 1976;42:32–41. [PubMed: 1065840]

90.

Meyer D. H., Fives-Taylor P. M. The role of Actinobacillus actinomycetemcomitans in the pathogenesis of periodontal disease. Trends Microbiol. 1997;5:224–228. [PubMed: 9211642]

91.

Meyer D. H., Lippmann J. E., Fives-Taylor P. M. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: a dynamic, multistep process. Infect. Immun. 1996;64:2988–2997. [PMC free article: PMC174179] [PubMed: 8757825]

92.

Meyer D. H., Mintz K. P., Fives-Taylor P. M. Models of invasion of enteric and periodontal pathogens into epithelial cells: a comparative analysis. Crit. Rev. Oral Biol. Med. 1997;8:389–409. [PubMed: 9391752]

93.

Meyer D. H., Sreenivasan P. K., Fives-Taylor P. M. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect. Immun. 1991;59:2719–2726. [PMC free article: PMC258078] [PubMed: 1855989]

94.

Michalowicz B. S. S. R. Diehl, Gunsolley J. C., Sparks B. S., Brooks C. N., Koertge T. E., Califano J. V., Burmeister J. A., Scheinken H. A. Evidence of a substantial genetic basis for risk of adult periodontitis. J. Periodontol. 2000;71:1699–1707. [PubMed: 11128917]

95.

Moore W. E. C., Moore L. V. H. The bacteria of periodontal disease. Periodontol. 2000. 1994;5:66–77. [PubMed: 9673163]

96.

Mousques T., Listgarten M. A., Phillips R. W. Effect of scaling and root planing on the composition of human subgingival microflora. J. Periodontal Res. 1980;15:144–151. [PubMed: 6445976]

97.

Offenbacher S. Periodontal diseases: pathogenesis. Ann. Periodontol. 1996;1:821–878. [PubMed: 9118282]

98.

O'Toole G., Kaplan H. B., Kolter R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000;54:49–79. [PubMed: 11018124]

99.

Page R. C., Beck J. D. Risk assessment for periodontal diseases. Int. Dent. J. 1997;47:61–87. [PubMed: 9448791]

100.

Papapanou P. N. Risk assessments in the diagnosis and treatment of periodontal diseases. J. Dent. Educ. 1998;62:822–839. [PubMed: 9847886]

101.

Pihlstrom B. L. Periodontal risk assessment, diagnosis and treatment planning. Periodontol. 2000. 2001;25:37–58. [PubMed: 11155181]

102.

Potempa J., Banbula A., Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol. 2000. 2000;24:153–192. [PubMed: 11276866]

103.

Rams T. E., Listgarten M. A., Slots J. Utility of 5 major putative periodontal pathogens and selected clinical parameters to predict periodontal breakdown in patients on maintenance care. J. Clin. Periodontol. 1996;23:346–354. [PubMed: 8739166]

104.

Ranney R. R., Debski B. F., Tew J. G. Pathogenesis of gingivitis and periodontal disease in children and young adults. Pediatr. Dent. 1981;3:89–100.

105.

Robertson P. B., Lantz M., Marucha P. T., Kornman K. S., Trummel C. L., Holt S. C. Collagenolytic activity associated with Bacteriodes species and Actinobacillus actinomycetemcomitans. J. Periodontal Res. 1982;17:275–283. [PubMed: 6125580]

106.

Ruben M. P. Periodontosis—an analysis and clarification of its status as a disease entity. J. Periodontol. 1979;50:311–315. [PubMed: 379300]

107.

Saarela M., Lippmann J. E., Meyer D. H., Fives-Taylor P. M. Actinobacillus actinomycetemcomitans apaH is implicated in invasion of epithelial cells. J. Dent. Res. 1999;78(Special Issue):259.

108.

Sandros J., Madianos P. N., Papapanou P. N. Cellular events concurrent with Porphyromonas gingivalis invasion of oral epithelium in vitro. Eur. J. Oral Sci. 1996;104:363– 371. [PubMed: 8930584]

109.

Sandros J., Papapanou P., Dahlen G. Porphyromonas gingivalis invades oral epithelial cells in vitro. J. Periodontal Res. 1993;28:219–226. [PubMed: 8388449]

110.

Saxén L. Heredity of juvenile periodontitis. J. Clin. Periodontol. 1980;7:276–288. [PubMed: 6936406]

111.

Saxén L., Nevanlinna H. R. Autosomal recessive inheritance of juvenile periodontitis: a test of a hypothesis. Clin. Genet. 1984;25:332–335. [PubMed: 6713708]

112.

Sbordone L., Ramaglia L., Gulletta E., Iacono V. Recolonization of the subgingival microflora after scaling and root planing in human periodontitis. J. Periodontol. 1990;61:579–584. [PubMed: 2213468]

113.

Schenkels L. C., Veerman E. C., Nieuw Amerongen A. V. Biochemical composition of human saliva in relation to other mucosal fluids. Crit. Rev. Oral Biol. Med. 1995;6:161–175. [PubMed: 7548622]

114.

Schonwetter B. S., Stolzenberg E. D., Zasloff M. A. Epithelial antibiotics induced at sites of inflammation. Science. 1995;267:1645– 1648. [PubMed: 7886453]

115.

Shenker B. J., Vitale L. A., Welham D. A. Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect. Immun. 1990;58:3856–3862. [PMC free article: PMC313746] [PubMed: 2254014]

116.

Shenker B. J., Kushner M. E., Tsai C. C. Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans. Infect. Immun. 1982;38:986–992. [PMC free article: PMC347847] [PubMed: 7152684]

117.

Shenker B. J., McKay T., Datar S., Miller M., Chowhan R., Demuth D. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J. Immunol. 1999;162:4773–4780. [PubMed: 10202019]

118.

Shenker B. J., McArthur W. P., Tsai C. C. Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J. Immunol. 1982;128:148–154. [PubMed: 7054277]

119.

Slots J. Subgingival microflora and periodontal disease. J. Clin. Periodontol. 1979;6:351–382. [PubMed: 393729]

120.

Slots J. Bacterial specificity in adult periodontitis. A summary of recent work. J. Clin. Periodontol. 1986;13:912–917. [PubMed: 3466908]

121.

Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease: introduction. Periodontol. 2000. 1999;20:7–13. [PubMed: 10522220]

122.

Slots, J., and C. Chen. 1999. The oral microflora and human periodontal disease, p. 101–127. In G. W. Tannock (ed.), Medical Importance of the Normal Microflora. Kluwer Academic Publishers, London, United Kingdom.

123.

Slots J., Emrich L. J., Genco R. J., Rosling B. G. Relationship between some subgingival bacteria and periodontal pocket depth and gain or loss of periodontal attachment after treatment of adult periodontitis. J. Clin. Periodontol. 1985;12:540–552. [PubMed: 3860517]

124.

Slots J., Listgarten M. A. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J. Clin. Periodontol. 1988;15:85– 93. [PubMed: 3279073]

125.

Socransky S. S. Microbiology of periodontal disease: present status and future considerations. J. Periodontol. 1977;48:497–504. [PubMed: 333085]

126.

Socransky S. S. Criteria for the infectious agents in dental caries and periodontal disease. J. Clin. Periodontol. 1979;6(Extra Issue):16–19. [PubMed: 295292]

127.

Socransky S. S., Haffajee A. D. The bacterial etiology of destructive periodontal disease: current concepts. J. Periodontol. 1992;63:322–331. [PubMed: 1573546]

128.

Socransky S. S., Haffajee A. D., Cugini M. A., Smith C., Kent, Jr R. L. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 1998;25:134–144. [PubMed: 9495612]

129.

Sreenivasan P. K., Meyer D. H., Fives-Taylor P. M. Requirements for invasion of epithelial cells by Actinobacillus actinomycetemcomitans. Infect. Immun. 1993;61:1239–1245. [PMC free article: PMC281353] [PubMed: 8454326]

130.

Sugai M., Kawamoto T., Peres S. Y., Ueno Y., Komatsuzawa H., Fujiwara T., Kurihara H., Suginaka H., Oswald E. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 1998;66:5008–5019. [PMC free article: PMC108622] [PubMed: 9746611]

131.

Sundqvist G., Figdor D., Hänström L., Sörlin S., Sandström G. Phagocytosis and virulence of different stains of Porphyromonas gingivalis. Scand. J. Dent. Res. 1991;99:117–129. [PubMed: 2052893]

132.

Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal diseases. J. Clin. Periodontol. 1986;13:905–911. [PubMed: 3540019]

133.

Tinoco E., Sivakumar M., Preus H. The distribution and transmission of Actinobacillus actinomycetemcomitans in families with localized juvenile periodontitis. J. Clin. Periodontol. 1998;25:99–105. [PubMed: 9495608]

134.

Tsai C. C., McArthur W. P., Baehni P. C., Hammond B. F., Taichman N. S. Extraction and partial characterization of a leukotoxin from a plaque-derived gram-negative microorganism. Infect. Immun. 1979;25:427–439. [PMC free article: PMC414468] [PubMed: 113347]

135.

Tuite-McDonnell M., Griffen A. L., Moeschberger M. L., Dalton R. E., Fuerst P. A., Leys E. J. Concordance of Porphyromonas gingivalis colonization in families. J. Clin. Microbiol. 1997;35:455–461. [PMC free article: PMC229599] [PubMed: 9003615]

136.

Van Winkelhoff A. J., Tijhof C. J., de Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J. Periodontol. 1992;63:52–57. [PubMed: 1313103]

137.

Van Winkelhoff A. J., Rams T. E., Slots J. Systemic antibiotic therapy in periodontics. Periodontol. 2000. 1996;10:45–78. [PubMed: 9567937]

138.

Westfelt E. Rationale of mechanical plaque control. J. Clin. Periodontol. 1996;23:263–267. [PubMed: 8707987]

139.

Wilson M., Henderson B. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol. Rev. 1995;17:365–379. [PubMed: 8845187]

140.

Yuan A. P. C. Yang, Lee L., Chang D. B., Kuo S. H., Luh K. T. Actinobacillus actinomycetemcomtians with chest wall involvement and rib destruction. Chest. 1992;101:1450–1452. [PubMed: 1582318]

141.

Zambon J. J., Christersson L. A., Slots J. Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. J. Periodontol. 1983;54:707–711. [PubMed: 6358452]

142.

Zambon J. J., Haraszthy V. I., Hariharan G., Lally E. T., Demuth D. R. The microbiology of early-onset periodontitis: association of highly toxic Actinobacillus actinomycetemcomitans strains with localized juvenile periodontitis. J. Periodontol. 1996;67:282–290. [PubMed: 29539847]